UAB "Eletis Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,643,413 |
410,853 |
8,804 |
8,165 |
2,041 |
57.00 |
0.50 |
12,477 |
268,291 |
1 |
280,767 |
2023 |
---|
1,983,138 |
495,785 |
27,734 |
25,896 |
6,474 |
42.57 |
1.31 |
38,372 |
293,553 |
1 |
331,924 |
2024 |
---|
1,611,465 |
402,866 |
32,487 |
29,747 |
7,437 |
40.59 |
1.85 |
68,119 |
398,514 |
1 |
466,632 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
1,611,465 €-19 % *
Sales per employee (€)
402,866 €-19 % *
Profit before tax (€)
32,487 €17 % *
Net Profit (€)
29,747 €15 % *
Profit per employee (€)
7,437 €15 % *
Total profitability (%)
40.59 %-4.65 % *
Net profitability (%)
1.85 %41.22 % *
Equity (€)
68,119 €78 % *
Amounts Payable And Liabilities (€)
398,514 €36 % *
Non-current Assets (€)
1 €0 % *
CurrentAssets (€)
466,632 €41 % *